IP Library › Granted Patent US 8,551,998
Granted Patent B2
US 8,551,998 · App. 13/439,948 · Granted Oct 8, 2013

Delta opioid receptor agonist compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,551,998
App. No.
13/439,948
Granted
Oct 8, 2013
Kind
B2
Abstract

Compositions and methods for treatment of sexual dysfunctions by administering to a subject a pharmaceutical composition comprising a delta opioid receptor agonist in an amount effective to delay the onset of ejaculation in the subject during sexual stimulation.

Claims (3)

1. A delta opioid receptor agonist compound having the following formula:

4-((alpha-S)-alpha-((2S,5R)-2,5-Dimethyl-4-(3-flourobenzyl)-N,N-diethylbenzamide.

2. The delta opioid receptor agonist compound of claim 1 wherein the compound is combined with a pharmaceutically acceptable solution.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2012
From: VERSI, EBRAHIM
To: VERSI GROUP, LLC
Reel/Frame 028186/0765 →